Cannabidiol and CES1 Interactions in Healthy Subjects
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The proposed study will assess the drug interaction potential between oral cannabidiol
(Epidiolex®) and the carboxylesterase 1 (CES1) substrate methylphenidate (Ritalin®) in 12
healthy research subjects
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Collaborator:
State of Florida Consortium for Medical Marijuana Clinical Outcomes Research